MED
Medifast, Inc. · NYSE · Consumer Cyclical · USD · 10-K for 2025, filed 2026-02-17
Figures on this page computed 2026-11-08 12:40 UTC
Last close
13.15USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-17
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-17
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
-4.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
0.3%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-K for 2025, filed 2026-02-17
0.05Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
- 10-K for 2025, filed 2026-02-17
- 10-Q for 2025, filed 2026-10-26
0.1%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Growth is the furthest below its sector's middle: 0.04 against 0.44 on the market's range.
Against its rival
lens 4 of 9Measure by measure
behind on 2 of 4- Profit on each unit of sales-4.8%-4.6%Behind
Higher is better here.
- Return on the capital it usesn/an/an/a
Higher is better here.
- Sales growth over five years-16.2%-4.5%Behind
Higher is better here.
- Debt against equity0.050.46Ahead
Lower is better here.
- Gross margin71.3%5.7%Ahead
Higher is better here.
- Price against earningsn/an/an/a
Lower is better here.
The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.
Against Unifi, Inc., MED is behind on 2 of 4 measures.
Against Unifi, Inc., MED is behind on 2 of 4 measures.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-02-17
Profit on each unit of sales-4.8%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
Return on the capital it usesn/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
Sales growth over five years-16.2%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
Debt against equity0.05
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
Gross margin71.3%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD
Price against earningsn/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001628280-26-008656
- Reported in
- USD